SSE's strategic pivot towards more regulated and stable revenue sources is expected to mitigate the risks associated with its merchant energy and long-term project pipeline. This shift is seen as a ...

SSE’s strategic pivot towards more regulated and stable revenue sources is expected to mitigate the risks associated with its merchant energy and long-term project pipeline. This shift is seen as a ...

VANCOUVER, British Columbia, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Zymeworks Inc., a clinical-stage biotechnology company, has announced plans for its drug development pipeline ... in second-line biliary tract cancer (BTC) as early as 2Q-2025 Cash, cash ...

VANCOUVER, British Columbia, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline ... second-line BTC was accepted ...

VANCOUVER, British Columbia, Jan. 08, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel ... A BLA for zanidatamab in ...

Advance ZW171 and ZW191 in solid tumors in ongoing Phase 1 trials; and Continue to drive the progression of the broad and differentiated product pipeline of ADCs and multispecific ... A BLA for ...